CMBCAMBIUM BIO LIMITED

Announcement history available from 1 August 2025

Fromto
Date / TimeTitleTypeMSReport Codes
5 Aug 2026, 19:31Updated Securities Trading PolicyCompany Administration14013
30 July 2026, 18:51Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly ReportsMS19004, 19009
24 July 2026, 19:37Change in substantial holding - BWSubstantial Holders02002
24 July 2026, 19:07Cleansing NoticeSecurities Administration06018
24 July 2026, 19:04Application for quotation of securities - CMBOther06020
22 July 2026, 18:46Proposed issue of securities - CMBSecurities Administration06013
22 July 2026, 18:44Cambium Bio Raises A$1.0 Million via PlacementCapital RaisingMS06003
24 June 2026, 22:12Becoming a substantial holderSubstantial Holders02001
24 June 2026, 20:28Change in substantial holding - ZYBTSubstantial Holders02002
16 June 2026, 20:43Becoming a substantial holderSubstantial Holders02001
28 Apr 2026, 19:10Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly ReportsMS19003, 19008
23 Apr 2026, 23:01FDA Confirms Single Pivotal Trial Pathway for Elate OcularCompany UpdateMS11001
25 Mar 2026, 03:31Change of Directors Interest Notice - STDirector Interests02009
17 Mar 2026, 20:38Cleansing NoticeSecurities Administration06018
17 Mar 2026, 20:21Application for quotation of securities - CMBOther06020
17 Mar 2026, 00:23Results of General MeetingMeetings & Governance08003
20 Feb 2026, 20:39Half Year Report and AccountsFinancial ResultsMS03004, 03009, 03010, 03015, 03019
11 Feb 2026, 21:52Proposed issue of securities - CMBSecurities Administration06013
11 Feb 2026, 21:52Notice of General Meeting/Proxy FormPresentations06010, 08004, 08007, 14014
23 Jan 2026, 20:14Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly ReportsMS19002, 19007
20 Jan 2026, 19:19Proposed issue of securities - CMBSecurities Administration06013
20 Jan 2026, 19:19Cambium Bio Secures A$2.4 Million Strategic InvestmentCapital RaisingMS06003
28 Oct 2025, 02:50Quarterly Activities/Appendix 4C Cash Flow ReportQuarterly ReportsMS19001, 19006
28 Oct 2025, 02:20Corrective Appendix 3Y Terrence WaltsDirector Interests02009
24 Oct 2025, 19:18Change of Directors Interest Notice - TWDirector Interests02009
24 Oct 2025, 19:18Change of Directors Interest Notice - EWDirector Interests02009
17 Oct 2025, 21:26Amended ConstitutionSecurities Administration12012
17 Oct 2025, 03:09Cleansing noticeSecurities Administration06018
17 Oct 2025, 02:56Notification regarding unquoted securities - CMBOther06021
17 Oct 2025, 02:54Application for quotation of securities - CMBOther06020
17 Oct 2025, 02:09Results of Annual General MeetingMeetings & Governance08003
16 Oct 2025, 21:33Cambium AGM CEO addressPresentations03026, 15002
30 Sept 2025, 23:32Cambium Bio Signs Manufacturing MOU with Locus CellCompany Update11001
15 Sept 2025, 20:31Proposed issue of securities - CMBSecurities Administration06013
15 Sept 2025, 20:27Notice of Annual General Meeting and Proxy formMeetings & Governance08001, 08004
5 Sept 2025, 21:37Cambium Bio Signs Strategic MoU with Benta SASCompany UpdateMS11001
2 Sept 2025, 23:07Cambium Bio Signs US$2.0M plus Licensing DealCompany UpdateMS11001
30 Aug 2025, 02:00FY25 Appendix 4G and Corporate Governance StatementCompany Administration03024, 03025
30 Aug 2025, 01:56FY25 Appendix 4E and Annual ReportFinancial ResultsMS03001, 03002, 03003, 03011, 03012, 03013, 03020
29 Aug 2025, 19:23Cleansing noticeSecurities Administration06018
29 Aug 2025, 19:21Application for quotation of securities - CMBOther06020
27 Aug 2025, 21:35Update - Proposed issue of securities - CMBSecurities Administration06013
27 Aug 2025, 21:27Placement Participant UpdateCapital RaisingMS06003, 06009
1–43 of 43
1 / 1